在儿童中迁移的吸入金属外体的复杂管理:一个多学科的成功
Najat Id El Haj1, Maha Adnane2, Jihane Ziati3
1Thoracic Surgery, Université Hassan II, Casablanca, MAR.
Cureus
|October 24, 2024
概括
儿童的异物吸入 (FB) 由于各种症状而带来诊断挑战. 这一案例凸显了尖的牙突起的延迟诊断和迁移,需要先进的成像来移除.
科学领域:
- 儿科急救医学 儿科急救医学
- 胸部外科手术 胸部外科手术
- 胃肠病学 胃肠病学
背景情况:
- 外体 (FB) 吸入是一种频繁的儿科紧急情况,呈现形式多样化.
- 吸入外体的延迟诊断会增加并发症的风险,包括穿孔和迁移.
- 利的物体带来了独特的检索挑战,通常需要先进的干预.
研究的目的:
- 在儿童身上呈现一种罕见的吸入性尖异体迁移病例.
- 要突出与儿科患者的异物吸入相关的诊断困难.
- 审查文献并确定用于管理吸入外体的关键诊断线索.
主要方法:
- 一个13岁男孩的案例报告,他吸入了外来物体.
- 最初的诊断和检索尝试包括刚性支气管镜和胸腔切除术.
- 先进的成像 (CT扫描) 和食道镜对于最终诊断和切除至关重要.
主要成果:
- 一个吸入的牙在一周内从胸部迁移到胃膜.
- 最初的支气管镜和胸腔切除术未能定位或移除异物体.
- 腹腔皮层CT和胃肠食道镜成功地可视化并移除了物体.
结论:
- 儿童吸入外体诊断可能是复杂的,特别是在延迟或非典型症状的情况下.
- 利的外体需要高度的怀疑指数和对迁移的考虑.
- 多模式成像和内镜方法对于管理具有挑战性的儿科外体病例至关重要.
相关概念视频
Flail Chest-II
160
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
160
Inhaled Medications
237
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
237
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumothorax-II
121
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
121
Cystic Fibrosis: Management
143
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
143
Pulmonary Cycle: Exhalation
1.5K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.5K


